Director, ProActive Study Management
Peter Motteram is Director of ProActive Study Management with offices in both London, UK and Boston, US. He has been in the industry for over 30 years and has spent the last 20 years consulting with companies on their clinical trials strategy, project management and CRO outsourcing.
He originally trained in biochemistry at the Universities of Birmingham and London, and after working in a London teaching hospital, he started his pharmaceutical work at Sterling Research Group as GCP Quality Assurance auditor. He moved to Quintiles, first founding their Quality Assurance department and then leading and developing their Business Development group outside US. As General Manager of ClinTrials Research, Peter had responsibility for offices in the non-Americas regions. ClinTrials Research was at that time the third largest global clinical trials CRO and was the first to do an IPO.
Since founding ProActive Study Management, a significant component of Peter’s work has been in running training courses, both public and tailored to in-house needs.